Our facts exhibit that CK18 is persistently expressed in various epithelial cancers, Specifically adenocarcinomas. Both lack of CK18 expression in cancers derived from CK18 positive precursor cells and neo-expression in malignancies derived from CK18 beneficial precursors are usually linked to unfavorable tumor phenotype and disease consequence. M